101 Therapeutics
Developing Cures for Multiple Infectious Diseases
Startup101 Therapeutics is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2020. Developing Cures for Multiple Infectious Diseases. 101 Therapeutics was founded by Alec Goldberg and James Goldberg. Key investors include Awz Ventures. The company has 1-10 employees. Core technologies: Biologicals, Molecules.
The company follows a B2B business model. Product stage: Clinical Trial.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- Last RoundUndisclosed
- Awz VenturesLead
Alec GoldbergCo-founder & CEO
James GoldbergCo-founder
1 article covered by sources including www.deccanchronicle.com.
What does 101 Therapeutics do?
101 Therapeutics has developed the first-ever targeted glucocorticoid with all of the potency of steroids and none of the systemic toxicities. By targeting the host immune system rather than the pathogen itself, the company can effectively treat a multitude of infectious diseases, whether viral, parasitic, or bacterial.
Who founded 101 Therapeutics?
101 Therapeutics was founded in 2020 by Alec Goldberg (Co-founder & CEO), James Goldberg (Co-founder).
What sector is 101 Therapeutics in?
101 Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is 101 Therapeutics located?
101 Therapeutics is based in Tel Aviv-Yafo, Israel.